ClinicalTrials.Veeva

Menu

Prospective Clinical Evaluation of Three Prosthesis Re-cap, M2a-Magnum and C2a-taper.

F

Frederiksberg University Hospital

Status and phase

Completed
Phase 4

Conditions

Patients Undergoing a THR

Treatments

Device: Hip prosthesis (re-cap, m2a-magnum and C2a-taper)

Study type

Interventional

Funder types

Other

Identifiers

NCT00284674
KF-01-287.591

Details and patient eligibility

About

This evaluation is being conducted to evaluate the performance of thee prosthesis.

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Good general health of age (ASA I-II)
  • DEXA-scanning: lower limit for a 55 years old man
  • MRI normal vitality in caput
  • Willing to return for follow-up evaluations
  • Exclusion Criteria:
  • Subjects displaying any of the following contra-indications shall be excluded from this evaluation:
  • Inability to co-operate with and complete the study
  • Collum < 2 cm
  • Large cysts in caput
  • Mismatch between caput acetabulum
  • Caput necrosis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems